Cite
Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients
MLA
Longziekten, et al. Improved Survival of IPF Patients Treated With Antifibrotic Drugs Compared With Untreated Patients. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432122427&authtype=sso&custid=ns315887.
APA
Longziekten, Infection & Immunity, Platenburg, M. G. J. P., van Moorsel, C. H. M., Wiertz, I. A., Vorselaars, A. D. M., van der Vis, J. J., Veltkamp, M., & Grutters, J. C. (2023). Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients.
Chicago
Longziekten, Infection & Immunity, Mark G.J.P. Platenburg, Coline H.M. van Moorsel, Ivo A. Wiertz, Adriane D.M. Vorselaars, Joanne J. van der Vis, Marcel Veltkamp, and Jan C. Grutters. 2023. “Improved Survival of IPF Patients Treated With Antifibrotic Drugs Compared With Untreated Patients.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432122427&authtype=sso&custid=ns315887.